CELLULAR SCIENCES INC has a total of 46 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, environmental technology and machines are MESSADEK JALLAL, VIROTEX CORP and AMMON HERMANN P T.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | Australia | 5 | |
#5 | Canada | 5 | |
#6 | Mexico | 5 | |
#7 | Israel | 3 | |
#8 | China | 2 | |
#9 | New Zealand | 2 | |
#10 | Taiwan | 2 | |
#11 | South Africa | 2 | |
#12 | Brazil | 1 | |
#13 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Katz Stanley E | 25 |
#2 | Martin Alain | 20 |
#3 | Alain Martin | 3 |
#4 | Stanley E Katz | 1 |
Publication | Filing date | Title |
---|---|---|
WO03017928A2 | Method for treating bronchial constriction and bronchospam | |
US2003040542A1 | Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide | |
US2003039615A1 | Method for treating bronchial constriction and bronchospasm | |
WO0069431A1 | Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response | |
US5798388A | Method and composition for treating mammalian diseases caused by inflammatory response | |
NZ306832A | Compositions for treating mammalian diseases caused by inflammatory response |